Skip to content
ChickenStockChickenStock
ResearchTWST
Twist Bioscience logo

Twist Bioscience (TWST) stock

NASDAQ

$110-3.69%(-4.21)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-50.35x

Net loss — not comparable

P/B

15.47x

P/S

15.97x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q4)

Revenue increased 27.9% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

Based on the company earnings press release. These figures come before the periodic report and may include adjusted measures.

See the same quarter across three years →

Filed Nov 12, 2026 · 8-K · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Korean AI analysis available →

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

40 SEC filings
  • Leproust Emily M.Chief Executive Officer · Nov 3, 2026Open-market sale4,573 shares · $619K
    Avg. price $135.402558,187 shares held after
  • Finn Patrick JohnPresident and COO · Nov 3, 2026Open-market sale2,565 shares · $347K
    Avg. price $135.402180,278 shares held after
  • Green PaulaSVP of Human Resources · Nov 3, 2026Open-market sale1,007 shares · $136K
    Avg. price $135.402105,625 shares held after
  • Cho DennisSee Remarks · Nov 3, 2026Open-market sale949 shares · $128K
    Avg. price $135.40262,840 shares held after
  • WERNER ROBERT F.Chief Accounting Officer · Nov 3, 2026Open-market sale148 shares · $20K
    Avg. price $135.40242,769 shares held after
  • Finn Patrick JohnPresident and COO · Oct 23, 2026Open-market sale2,245 shares · $302K
    Avg. price $134.589182,843 shares held after
  • Laponis AdamChief Financial Officer · Oct 9, 2026Open-market sale2,462 shares · $385K
    Avg. price $156.304998,114 shares held after
  • Leproust Emily M.Chief Executive Officer · Oct 5, 2026Open-market sale4,548 shares · $919K
    Avg. price $202.149
    Show 8 price lots
    • 1,840 shares × $200.4379$369K
    • 1,017 shares × $202.3236$206K
    • 481 shares × $201.2556$97K
    • 432 shares × $203.6072$88K
    • 297 shares × $205.7772$61K
    • 290 shares × $204.7996$59K
    • 146 shares × $206.8449$30K
    • 45 shares × $207.4556$9K
  • Leproust Emily M.Chief Executive Officer · Oct 2, 2026Open-market sale45,736 shares · $8.6M
    Avg. price $188.884567,308 shares held after
  • Finn Patrick JohnPresident and COO · Oct 2, 2026Open-market sale25,714 shares · $4.9M
    Avg. price $188.884185,088 shares held after
  • Green PaulaSVP of Human Resources · Oct 2, 2026Open-market sale10,088 shares · $1.9M
    Avg. price $188.884106,632 shares held after
  • Cho DennisSee Remarks · Oct 2, 2026Open-market sale9,514 shares · $1.8M
    Avg. price $188.88463,789 shares held after
  • Laponis AdamChief Financial Officer · Oct 2, 2026Open-market sale8,057 shares · $1.5M
    Avg. price $188.884100,576 shares held after
  • WERNER ROBERT F.Chief Accounting Officer · Oct 2, 2026Open-market sale1,482 shares · $280K
    Avg. price $188.88442,917 shares held after
  • Leproust Emily M.Chief Executive Officer · Oct 1, 2026Open-market sale655 shares · $131K
    Avg. price $200613,044 shares held after
  • Leproust Emily M.Chief Executive Officer · Sep 24, 2026Open-market sale5,203 shares · $923K
    Avg. price $177.3797
    Show 10 price lots
    • 2,485 shares × $175.2313$435K
    • 945 shares × $176.3917$167K
    • 515 shares × $180.3911$93K
    • 501 shares × $183.7641$92K
    • 330 shares × $178.6683$59K
    • 164 shares × $177.1699$29K
    • 143 shares × $179.9331$26K
    • 83 shares × $184.603$15K
    • 21 shares × $181.4519$4K
    • 16 shares × $182.5$3K
  • Leproust Emily M.Chief Executive Officer · Sep 21, 2026Open-market sale1,687 shares · $279K
    Avg. price $165.491618,902 shares held after
  • Cho DennisSee Remarks · Sep 21, 2026Open-market sale348 shares · $58K
    Avg. price $165.49173,303 shares held after
  • Green PaulaSVP of Human Resources · Sep 21, 2026Open-market sale294 shares · $49K
    Avg. price $165.491116,720 shares held after
  • Leproust Emily M.Chief Executive Officer · Sep 17, 2026Open-market sale316,188 shares · $50.0M
    Avg. price $158.1318
    Show 5 price lots
    • 232,173 shares × $158.0876$36.7M
    • 32,260 shares × $157.486$5.1M
    • 23,884 shares × $159.5315$3.8M
    • 14,493 shares × $160.4392$2.3M
    • 13,378 shares × $155.4568$2.1M

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Twist Bioscience (TWST) stock information

NASDAQ

Twist Bioscience (TWST) is listed on NASDAQ. Its market capitalization is about $6.9B. On trailing-twelve-month earnings the P/E ratio is -50.35, and the P/B ratio is 15.47. Return on equity is -30.7%. These figures are computed in-house from official filings and are reference information only.

Twist Bioscience — frequently asked questions

What is the P/E ratio of Twist Bioscience (TWST)?
On a trailing-twelve-month basis, TWST trades at a P/E ratio of -50.35. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Twist Bioscience?
TWST has a market capitalization of about $6.9B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.